Immunomodulation with Glatiramer Acetate Prevents Long-Term Inflammatory Pain

REFERENCES

• Aharoni R., Kayhan B., Eilam R., Sela M., Arnon R. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proceedings of the National Academy of Sciences of the USA 2003; 100: 14157–14162
   PubMed Web of Science ®Google Scholar
• Angelov D. N., Waibel S., Guntinas-Lichius O., Lenzen M., Neiss W. F., Tomov T. L., Yoles E., Kipnis J., Schori H., Reuter A., Ludolph A., Schwartz M. Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the USA 2003; 100: 4790–4795
   PubMed Web of Science ®Google Scholar
• Arnon R., Aharoni R. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proceedings of the National Academy of Sciences of the USA 2004; 101(Suppl 2)4593–4598
   Google Scholar
• Asensio V. C., Campbell I. L. Chemokines in the CNS: Plurifunctional mediators in diverse states. Trends in Neurosciences 1999; 22: 504–512
   PubMed Web of Science ®Google Scholar
• Benner E. J., Mosley R. L., Destache C. J., Lewis T. B., Jackson-Lewis V., Gorantla S., Nemachek C., Green S. R., Przedborski S., Gendelman H. E. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences of the USA 2004; 101: 9435–9440
   PubMed Web of Science ®Google Scholar
• Bennett G. J., Xie Z. K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1998; 33: 87–107
   Google Scholar
• Chen M., Valenzuela R. M., Dhib-Jalbut S. Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor. Journal of Neurological Sciences 2003; 215: 37–44
   PubMed Web of Science ®Google Scholar
• Couzin J. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science 2004; 306: 384–385
   PubMed Web of Science ®Google Scholar
• DeLeo J.Z., Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001; 90: 1–6
   PubMed Web of Science ®Google Scholar
• Dowdall T., Robinson I., Meert T. F. Comparison of five different rat models of peripheral nerve injury. Pharmacology Biochemistry and Behavior 2005; 80: 93–108
   PubMed Web of Science ®Google Scholar
• Hesselgesser J., Horuk R. Chemokine and chemokine receptor expression in the central nervous system. Journal of Neurovirology 1999; 5: 13–26
   PubMed Web of Science ®Google Scholar
• Ho L., Qin W., Stetka B. S., Pasinetti G. M. Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?. CNS Drugs 2006; 20: 85–98
   PubMed Web of Science ®Google Scholar
• Hughes P. M., Batham M. S., Frentzel S., Mir A., Perry V. H. Expression of fractalkine (CX3CL1) and its receptor (CX3CR1), during acute and chronic inflammation in the rodent CNS. Glia 2002; 37: 314–327
   PubMed Web of Science ®Google Scholar
• Jung S., Aliberti J., Graemmel P., Sunshine M. J., Kreutzberg G. W., Sher A., Littman D. R. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Molecular and Cellular Biology 2000; 20: 4106–4114
   PubMed Web of Science ®Google Scholar
• Kipnis J., Cohen H., Cardon M., Ziv Y., Schwartz M. T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proceedings of the National Academy of Sciences of the USA 2004; 101: 8180–8185
   PubMed Web of Science ®Google Scholar
• Ledeboer A., Jekich B. M., Sloane E. M., Mahoney J. H., Langer S. J., Milligan E. D., Martin D., Maier S. F., Johnson K. W., Leinwand L. A., Chavez R. A., Watkins L. R. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behavior and Immunity 2007; 21: 686–698
   PubMed Web of Science ®Google Scholar
• Milligan E. D., Zapata V., Chacur M., Schoeniger D., Biedenkapp J., O’Connor K. A., Verge G. M., Chapman G., Green P., Foster A. C., Naeve G. S., Maier S. F., Watkins L. R. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. European Journal of Neuroscience 2004; 20: 2294–2302
   PubMed Web of Science ®Google Scholar
• Plunkett J. A., Yu C. G., Easton J. M., Bethea J. R., Yezierski R. P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Experimental Neurology 2001; 168: 144–154
   PubMed Web of Science ®Google Scholar
• Raghavendra V., Tanga F. Y., DeLeo J. A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. European Journal of Neuroscience 2004; 20: 467–473
   PubMed Web of Science ®Google Scholar
• Rodrigues A. D. Impact of CYP2C9 genotype on pharmacokinetics: Are all cyclooxygenase inhibitors the same?. Drug Metabolism and Disposition 2005; 33: 1567–1575
   PubMed Web of Science ®Google Scholar
• Schori H., Kipnis J., Yoles E., WoldeMussie E., Ruiz G., Wheeler L. A., Schwartz M. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and occular hypertension: Implications for glucoma. Proceedings of the National Academy of Sciences of the USA 2001; 98: 3398–3403
   PubMed Web of Science ®Google Scholar
• Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990; 43: 205–218
   PubMed Web of Science ®Google Scholar
• Verge G. M., Milligan E. D., Maier S. F., Watkins L. R., Naeve G. S., Foster A. C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. European Journal of Neuroscience 2004; 20: 1150–1160
   PubMed Web of Science ®Google Scholar
• Watkins L. R., Maier S. F., Goehler L. E. Immune activation: The role of pro-inflammation, illness responses and pathological pain states. Pain 1995; 63: 289–302
   PubMed Web of Science ®Google Scholar
• Weiner H. L. Oral tolerance with copolymer 1 for the treatment of multiple sclerosis. Proceedings of the National Academy of Sciences of the USA 1999; 96: 3333–3335
   PubMed Web of Science ®Google Scholar